Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 8, 2005, Pages 613-615

  Nan, Daniel N ^a   Fernández Ayala, Marta ^a   García Ibarbia, Carmen ^a   Gutíerrez Santiago, Mar ^a   Hernández, Jose Luis ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BCG VACCINE; GLIBENCLAMIDE; PREDNISONE;

ABDOMINAL PAIN; AGED; ANAPHYLACTOID PURPURA; ARTICLE; BLADDER CARCINOMA; BRAIN INFARCTION; CANCER IMMUNOTHERAPY; CANCER RELAPSE; CASE REPORT; COLONOSCOPY; DIABETES MELLITUS; DIARRHEA; DIGESTIVE SYSTEM DISEASE; ELBOW DISEASE; ENDOSCOPIC SURGERY; ERYTHEMA; FACE DISORDER; FEVER; HEMIPARESIS; HUMAN; HUMAN TISSUE; HYPERTENSION; LEG DISEASE; LEUKOCYTOCLASTIC VASCULITIS; MALE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECTUM MUCOSA; RECTUM ULCER; SKIN BIOPSY; SKIN DEFECT; TRANSITIONAL CELL CARCINOMA; TUBERCULIN TEST;

ADMINISTRATION, INTRAVESICAL; AGED; HUMANS; MALE; MYCOBACTERIUM BOVIS; PURPURA, SCHOENLEIN-HENOCH; URINARY BLADDER NEOPLASMS;

EID: 24644511186     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540510035300     Document Type: Article

References (14)

1. Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 1986;135:272-4.
2. Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600.
3. Morales A. Long-term results and complications of intracavitary bacillus Calmette-Guérin therapy for bladder cancer. J Urol 1984;132:457-9.
4. Steg A, Sicard D, Leleu C, DeBre B, Boccon-Gibod L. Systemic complications of intravesical BCG therapy for bladder cancer. Lancet 1985;2:899.
5. Steg A, Leleu C, DeBre B, Boccon-Gibod L, Sicard D. Systemic BCG infection, 'BCGitis' in patient treated by intravesical BCG therapy for bladder cancer. J Eur Urol 1989;16:161-4.
6. Lamm DL. Complications of bacillus Calmette-Guérin immunotherapy. Urol Clin North Am 1992;19:565-72.
7. Prescott S, Jacksom AM, Hawkyard SJ, Alexandroff AB, James K. Mechanisms of action of intravesical bacillus Calmette-Guérin: local immune mechanisms. Clin Infect Dis 2000;31:S91-3.
8. Bast RC Jr, Zbar B, Borsos T, Rapp HJ. BCG and cancer. N Engl J Med 1974;290:1413-20.
9. Durand JM, Roubcek C, Retornaz F, Cretel E, Payan MJ, Bernard JP, Kaplanski G, Soubeyrand J. Cryoglobulinemia after intravesical administration of Bacille Calmette-Guérin. Clin Infect Dis 1998;26:497-8.
10. Saporta L, Gumus E, Karadag H, Kuran B, Miroglu C. Reiter syndrome following intracavitary BCG administration. Scand J Urol Nephrol 1997;31:211-2.
11. Han BG, Choi SO, Shin SJ, Kim HY, Jung SH, Lee KH. A case of Henoch-Schönlein purpura in disseminated tuberculosis. Korean J Intern Med 1995;10:54-9.
12. Islek I, Muslu A, Totan M, Gok F, Sanic A. Henoch-Schönlein purpura and pulmonary tuberculosis. Pediatr Int 2002;44:545-6.
13. Yano S. Henoch-Schonlein purpura associated with pulmonary Mycobacterium avium-intracellulare complex. Intern Med 2004;43:843-5.
14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.